These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

272 related articles for article (PubMed ID: 11564886)

  • 1. Induction of distinct [URE3] yeast prion strains.
    Schlumpberger M; Prusiner SB; Herskowitz I
    Mol Cell Biol; 2001 Oct; 21(20):7035-46. PubMed ID: 11564886
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prion-inducing domain of yeast Ure2p and protease resistance of Ure2p in prion-containing cells.
    Masison DC; Wickner RB
    Science; 1995 Oct; 270(5233):93-5. PubMed ID: 7569955
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The [URE3] prion is an aggregated form of Ure2p that can be cured by overexpression of Ure2p fragments.
    Edskes HK; Gray VT; Wickner RB
    Proc Natl Acad Sci U S A; 1999 Feb; 96(4):1498-503. PubMed ID: 9990052
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [URE3] as an altered URE2 protein: evidence for a prion analog in Saccharomyces cerevisiae.
    Wickner RB
    Science; 1994 Apr; 264(5158):566-9. PubMed ID: 7909170
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The cellular concentration of the yeast Ure2p prion protein affects its propagation as a prion.
    Crapeau M; Marchal C; Cullin C; Maillet L
    Mol Biol Cell; 2009 Apr; 20(8):2286-96. PubMed ID: 19225154
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The prion domain of yeast Ure2p induces autocatalytic formation of amyloid fibers by a recombinant fusion protein.
    Schlumpberger M; Wille H; Baldwin MA; Butler DA; Herskowitz I; Prusiner SB
    Protein Sci; 2000 Mar; 9(3):440-51. PubMed ID: 10752606
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The prion model for [URE3] of yeast: spontaneous generation and requirements for propagation.
    Masison DC; Maddelein ML; Wickner RB
    Proc Natl Acad Sci U S A; 1997 Nov; 94(23):12503-8. PubMed ID: 9356479
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The mechanisms of [URE3] prion elimination demonstrate that large aggregates of Ure2p are dead-end products.
    Ripaud L; Maillet L; Cullin C
    EMBO J; 2003 Oct; 22(19):5251-9. PubMed ID: 14517262
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Internal initiation drives the synthesis of Ure2 protein lacking the prion domain and affects [URE3] propagation in yeast cells.
    Komar AA; Lesnik T; Cullin C; Merrick WC; Trachsel H; Altmann M
    EMBO J; 2003 Mar; 22(5):1199-209. PubMed ID: 12606584
    [TBL] [Abstract][Full Text] [Related]  

  • 10.
    Edskes HK; Mukhamedova M; Edskes BK; Wickner RB
    Genetics; 2018 Jul; 209(3):789-800. PubMed ID: 29769283
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Conservation of a portion of the S. cerevisiae Ure2p prion domain that interacts with the full-length protein.
    Edskes HK; Wickner RB
    Proc Natl Acad Sci U S A; 2002 Dec; 99 Suppl 4(Suppl 4):16384-91. PubMed ID: 12177423
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reporter assay systems for [URE3] detection and analysis.
    Brachmann A; Toombs JA; Ross ED
    Methods; 2006 May; 39(1):35-42. PubMed ID: 16762564
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The [URE3] yeast prion results from protein aggregates that differ from amyloid filaments formed in vitro.
    Ripaud L; Maillet L; Immel-Torterotot F; Durand F; Cullin C
    J Biol Chem; 2004 Dec; 279(49):50962-8. PubMed ID: 15456789
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A promiscuous prion: efficient induction of [URE3] prion formation by heterologous prion domains.
    Ross CD; McCarty BR; Hamilton M; Ben-Hur A; Ross ED
    Genetics; 2009 Nov; 183(3):929-40. PubMed ID: 19752212
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Two prion-inducing regions of Ure2p are nonoverlapping.
    Maddelein ML; Wickner RB
    Mol Cell Biol; 1999 Jun; 19(6):4516-24. PubMed ID: 10330190
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The [URE3] phenotype: evidence for a soluble prion in yeast.
    Fernandez-Bellot E; Guillemet E; Ness F; Baudin-Baillieu A; Ripaud L; Tuite M; Cullin C
    EMBO Rep; 2002 Jan; 3(1):76-81. PubMed ID: 11751580
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prion generation in vitro: amyloid of Ure2p is infectious.
    Brachmann A; Baxa U; Wickner RB
    EMBO J; 2005 Sep; 24(17):3082-92. PubMed ID: 16096644
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Yeast prions: could they be exaptations? The URE2/[URE3] system in Kluyveromyces lactis.
    Safadi RA; Talarek N; Jacques N; Aigle M
    FEMS Yeast Res; 2011 Feb; 11(1):151-3. PubMed ID: 21235712
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stability, folding, dimerization, and assembly properties of the yeast prion Ure2p.
    Thual C; Bousset L; Komar AA; Walter S; Buchner J; Cullin C; Melki R
    Biochemistry; 2001 Feb; 40(6):1764-73. PubMed ID: 11327838
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The yeast prion [URE3] can be greatly induced by a functional mutated URE2 allele.
    Fernandez-Bellot E; Guillemet E; Cullin C
    EMBO J; 2000 Jul; 19(13):3215-22. PubMed ID: 10880435
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.